Defense Health Agency Contracting Activity - DHACA Grants

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Lupus Research Program Transformative Vision Award supports interventional research aimed at near-term improvement in the quality of life of people living with lupus; clinical trials are allowed but animal studies are not. Eligibility is listed as unrestricted (open to any eligible entity type, subject to clarification in the announcement), so research-capable organizations may apply. Applications must include preliminary data and at least one lupus consumer advocate on the team. No specific award amount is stated; the deadline is August 24, 2026.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Lupus Research Program Idea Award supports innovative, high-risk/high-reward research that could lead to major advances relevant to lupus; clinical trials are not allowed and preliminary data are optional. Eligibility is listed as unrestricted (open to any eligible entity type, subject to clarification in the announcement), and early-career investigators are explicitly eligible to serve as PIs. No specific award amount is stated; the deadline is August 24, 2026.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Lupus Research Program Impact Award supports high-risk/high-reward research with potential to make a major impact on lupus research or disease; clinical trials are not allowed and preliminary data are encouraged but not required. Eligibility is listed as unrestricted (open to any eligible entity type, subject to clarification in the announcement), so research-capable organizations may apply. No specific award amount is stated; the deadline is August 24, 2026.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Lupus Research Program Transformative Vision Development Award supports planning, development, and pilot studies that generate preliminary data and demonstrate feasibility for a future interventional lupus study; it allows phase 0/1 clinical trials but not phase 2/3 trials or animal studies. Eligibility is listed as unrestricted (open to any eligible entity type, subject to clarification in the announcement), and applications must include at least one lupus consumer advocate on the team. No specific award amount is stated; the deadline is August 24, 2026.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Prostate Cancer Physician Research Award funds a mentored research experience to prepare physicians with clinical duties for prostate cancer research careers. The PI must be an early-career clinician (last year of residency/fellowship or within five years of a faculty appointment) and the application must include an experienced mentor and a development plan. Eligibility is otherwise stated as unrestricted, so review the program announcement for specific organization categories. Award amounts are not specified here.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Lung Cancer Patient-Centered Outcomes and Survivorship Award funds research to improve lung cancer outcomes and patient experience, and may include translational, clinical, or pilot clinical research. The research team must include an advocate who is a lung cancer patient/survivor or caregiver. Eligibility is otherwise stated as unrestricted, so review the program announcement for specific organization categories. Award amounts are not specified here.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Lung Cancer Idea Development Award funds high-risk, high-reward early-stage lung cancer research, including a New Investigator category for applicants early in their faculty appointments. Preliminary data supporting feasibility are required, though they need not come from lung cancer studies specifically. Eligibility is stated as unrestricted, so review the program announcement for specific organization categories. Award amounts are not specified here.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Prostate Cancer Data Science Award funds research using quantitative and analytical approaches, including AI/machine learning, bioinformatics, and digital pathology, on large or complex prostate cancer datasets. The mechanism allows multiple principal investigators, with an initiating and partnering PI submission structure. Eligibility is stated as unrestricted, so review the program announcement for specific organization categories. Award amounts are not specified here.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Prostate Cancer Idea Development Award funds innovative new prostate cancer research ideas addressing the program's overarching challenges. A New Investigator category encourages early-career applicants (within 10 years of their terminal degree), who must identify an experienced prostate cancer research collaborator. Eligibility is otherwise stated as unrestricted, so review the program announcement for specific organization categories. Award amounts are not specified here.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Lung Cancer Translational Research Award funds advanced translational lung cancer research, including late-stage preclinical work or pilot clinical trials, addressing the program's FY26 areas of emphasis. Eligibility is stated as unrestricted (open to any eligible entity type), so review the program announcement for specific organization categories. Award amounts are not specified here. This is a research-focused defense health opportunity.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Prostate Cancer Early Investigator Research Award funds prostate cancer research conducted by early-career investigators with fewer than three years of postdoctoral experience, guided by an experienced mentor. Applications must include at least one experienced prostate cancer research mentor and a researcher development plan. Eligibility is otherwise stated as unrestricted, so review the program announcement for specific organization categories. Award amounts are not specified here.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Hearing Restoration Focused Research Award funds preclinical and clinical research to accelerate drug discovery and therapeutics for hearing restoration after military-relevant auditory injury. It cannot support clinical trials, tinnitus research, or vestibular research, and offers two funding levels including a partnering-PI option. Eligibility is stated as unrestricted, so review the program announcement for specific organization categories. Award amounts are not specified here.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Vision Research Program Mentored Clinical Research Award funds patient-oriented vision injury research by clinicians in training, paired with an established clinician or PhD scientist serving as PI and mentor. It cannot support preclinical research or clinical trials, and applicants must submit IRB/ethics approval or exemption by January 1, 2027. Eligibility is otherwise stated as unrestricted, so review the program announcement for specific organization categories. Award amounts are not specified here.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Reconstructive Transplant Concept Award funds exploration of highly innovative, untested concepts in reconstructive transplantation, and does not support clinical trials. Preliminary data are not allowed, but applications must show a clear rationale and the ability to produce interpretable results. Early-career investigators at or above the postdoctoral fellow level are encouraged to apply, and eligibility is otherwise stated as unrestricted. Award amounts are not specified here.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Duchenne Muscular Dystrophy Research Program Idea Development Award funds early-stage, high-risk/high-reward research with the potential to advance outcomes for individuals with Duchenne muscular dystrophy. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement, and offers separate categories for established and early-career or transitioning investigators. Preliminary data relevant to DMD are required, and clinical trials are not allowed. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Duchenne Muscular Dystrophy Research Program Clinical/Translational Research Award funds advanced translational research moving promising DMD ideas toward clinical application, at two funding levels by project size and complexity. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement, and a partnering PI option supports collaborations. Preliminary data are required for all applications, and pilot clinical trials and clinical trial readiness studies are allowed. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Peer Reviewed Medical Research Program Clinical Trial Award funds clinical trials addressing congressionally directed FY26 topic areas, across three funding levels by trial phase and size. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement, so a range of research organizations may apply. Total cost caps run from about $800,000 for a planning phase up to roughly $20M for the largest trials, and animal studies are not supported. Applicants must complete all preclinical lab work before the award start date.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Peer Reviewed Medical Research Program Platform Clinical Translation Award funds translational development and early-phase clinical trials of broadly applicable clinical technologies addressing congressionally directed FY26 topic areas relevant to service members, veterans, and their families. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement, and multiple principal investigators are allowed. Total cost caps are about $15M per award, and a PI-convened external advisory board including a patient advocate is required. Funding is milestone-based and contingent on future-year appropriations.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Alzheimer's Research Program Transforming Research Award funds non-incremental research on reducing risk and preventing Alzheimer's disease and related dementias, focused on risk factor knowledge or risk reduction solutions. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement. Clinical research is allowed but clinical trials and animal research are prohibited, preliminary data are required, and community collaboration is required when prospectively enrolling human subjects. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Alzheimer's Research Program Transforming Diagnosis Award funds solutions-oriented research that reduces barriers to diagnosis, disease monitoring, and prognosis for Alzheimer's disease and related dementias. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement. Clinical research is allowed but clinical trials and animal research are prohibited, preliminary data are required, and community collaboration is required when prospectively enrolling human subjects. No specific award amount is stated.